Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector

Cancer Gene Therapy

Volumn 10, Issue 11, 2003, Pages 833-839

  Kimura, Takahiro ^a   Ohashi, Toya ^a   Kikuchi, Tetsuro ^a   Kiyota, Hiroshi ^a   Eto, Yoshikatsu ^a   Ohishi, Yukihiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; CD40 ligand; Immunogene therapy; Retrovirus vector

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; GENE PRODUCT; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOGENETICS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE; TUMOR IMMUNITY;

ANIMALS; ANTIBODY FORMATION; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GENETIC VECTORS; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, INBRED C3H; MICE, SCID; RETROVIRIDAE; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0242607872     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700627     Document Type: Article

References (19)

1. Eto M, Harada M, Tamada K, et al. Antitumor activity of interleukin-12 against murine bladder cancer. J Urol. 2000;163:1549-1552.
2. Grossmann ME, Brown MP, Brenner MK. Antitumor responses induced by transgenic expression of CD40 ligand. Hum Gene Ther. 1997;8:1935-1943.
3. Nakajima A, Kodama T, Morimoto S, et al. Antitumor effect of CD40 Ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. J Immunol. 1998; 161:1901-1907.
4. Kikuchi T, Crystal RG. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells. Hum Gene Ther. 1999;10:1375-1387.
5. Durie FH, Foy TM, Masters SR, et al. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today. 1994;15:406-411.
6. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998;16:111-135.
7. Jenkins MK. The ups and downs of T cell costimulation. Immunity. 1994;1:443-446.
8. Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994;180:1263-1272.
9. Cella M, Scheidegger D, Palmer-Lehmann K, et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 1996;184:747-752.
10. Koch F, Stanzl U, Jennewein P, et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med. 1996; 184:741-746.
11. Robbins PB, Yu XJ, Skelton DM, et al. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol. 1997;71:9466-1974.
12. Pear WS, Nolan GP, Scott ML, et al. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA. 1993;90:8392-8396.
13. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA. 1988;85:6460-6464.
14. Joki T, Kikuchi T, Akasaki Y et al. Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12. Int J Cancer. 1999;82:714-720.
15. Akasaki Y, Kikuchi T, Homma S, et al. Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother. 2001;24:106-113.
16. Kikuchi T, Akasaki Y, Joki T, et al. Antitumor activity of interleukin-18 on mouse glioma cells. J Immunother. 2000;23:184-189.
17. + and B lymphocytes in transplantation immunity. Transplantation. 1993;55:1356-1361.
18. Fujieda M, Oishi N, Kurashige T. Antibody to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol. 1997;107: 120-126.
19. Loskog A, Bjorkland A, Brown MP, et al. Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer. J Urol. 2001;166:1093-1097.